Medication info
TwinEco Tablet 80/5 mg

TwinEco Tablet 80/5 mg

Prescription medicationTabletOral
Ingredient · strength
Telmisartan›40mg / 1 tabletAmlodipine Besylate›6.935mg / 1 tablet
Manufacturer / importer
Sears Pharmaceuticals Co., Ltd.
Appearance
White or whitish rectangular tablet
Packaging
30 tablets/bottle
Approval status
Active

MFDS item code 201902541 · Approved 2019.04.23 · Insurance code 689000680

Summary

Main use
Treatment of essential hypertension not controlled with monotherapy
Who takes it
Adults · Children
Adult dose
The recommended dose of this medicine is 1 tablet once daily, taken with water, with or without food. If possible, it is recommended that it be taken at the same time each day (e.g., in the morning). Before starting this medicine, it is recommended that the dose be adjusted using the individual components (amlodipine or telmisartan). However, if blood pressure is not controlled with the individual components as follows, switching directly to this medicine may be considered. - 40/5 mg: For patients whose blood pressure is not adequately controlled with amlodipine 5 mg or telmisartan 40 mg. - 80/5 mg: For patients whose blood pressure is not adequately controlled with amlodipine 5 mg or this medicine 40/5 mg. - 40/10 mg: For patients whose blood pressure is not adequately controlled with amlodipine 10 mg. ○ Patients with renal impairment: No dose adjustment is necessary in patients with mild to moderate renal impairment. For patients with severe renal impairment, however, it is recommended to start treatment at a low dose and increase the dose gradually. Periodic monitoring of serum potassium and creatinine levels is also recommended. Telmisartan is not removed by hemodialysis. ○ Patients with hepatic impairment: The daily dose of telmisartan should not exceed 40 mg in patients with mild or moderate hepatic impairment. ◦ Elderly patients: The usual amlodipine dosage regimen is recommended for elderly patients, but caution should be exercised when increasing the dose (see section '3. Patients who should use this medicine with caution'). In elderly patients aged 75 years or older, amlodipine clearance is reduced; therefore, start treatment at a low dose and increase the dose gradually.
Child dose
○ Pediatric patients: Use of this medicine is not recommended because its safety and efficacy have not been established in pediatric patients 18 years of age or younger.

Ingredients

Manufacturer
Sears Pharmaceuticals Co., Ltd.

Efficacy & effects

Treatment of essential hypertension not controlled with monotherapy

  • Essential hypertension
View approved original text

This medication may be beneficial for patients with essential hypertension who have difficulty controlling their blood pressure with monotherapy of either amlodipine or telmisartan. It combines the effects of both medications to manage blood pressure more effectively. It dilates blood vessels, lowers blood pressure, and reduces strain on the heart, thereby improving hypertension. It is suitable for those who struggle to control their hypertension and is a good choice for maintaining stable blood pressure levels. It is used in the treatment of essential hypertension.

How to take

Adult dose

The recommended dose of this medicine is 1 tablet once daily, taken with water, with or without food. If possible, it is recommended that it be taken at the same time each day (e.g., in the morning). Before starting this medicine, it is recommended that the dose be adjusted using the individual components (amlodipine or telmisartan). However, if blood pressure is not controlled with the individual components as follows, switching directly to this medicine may be considered. - 40/5 mg: For patients whose blood pressure is not adequately controlled with amlodipine 5 mg or telmisartan 40 mg. - 80/5 mg: For patients whose blood pressure is not adequately controlled with amlodipine 5 mg or this medicine 40/5 mg. - 40/10 mg: For patients whose blood pressure is not adequately controlled with amlodipine 10 mg. ○ Patients with renal impairment: No dose adjustment is necessary in patients with mild to moderate renal impairment. For patients with severe renal impairment, however, it is recommended to start treatment at a low dose and increase the dose gradually. Periodic monitoring of serum potassium and creatinine levels is also recommended. Telmisartan is not removed by hemodialysis. ○ Patients with hepatic impairment: The daily dose of telmisartan should not exceed 40 mg in patients with mild or moderate hepatic impairment. ◦ Elderly patients: The usual amlodipine dosage regimen is recommended for elderly patients, but caution should be exercised when increasing the dose (see section '3. Patients who should use this medicine with caution'). In elderly patients aged 75 years or older, amlodipine clearance is reduced; therefore, start treatment at a low dose and increase the dose gradually.

Child dose

○ Pediatric patients: Use of this medicine is not recommended because its safety and efficacy have not been established in pediatric patients 18 years of age or younger.

Precautions

This medication can cause serious harm to the fetus if used during pregnancy, especially in the second and third trimesters, so it should not be taken by pregnant women or women who may become pregnant. Patients with allergies to any of the ingredients in this medication or those with certain heart conditions, liver impairment, hypotension, renal impairment, and biliary obstruction should also refrain from taking this medication. Patients with primary aldosteronism or certain heart valve disorders, those with liver dysfunction, gastrointestinal diseases, and renal vascular hypertension should use this medication cautiously. Common side effects while taking this medication include dizziness and peripheral edema, and there is a rare risk of serious side effects such as fainting or heart problems, requiring careful monitoring. During pregnancy, this medication should not be initiated or continued, and if pregnancy is confirmed, it should be discontinued immediately and an alternative treatment should be sought. Due to the risk of hypotension, patients with low fluid or salt levels should correct their condition before taking this medication, and if symptoms of hypotension appear during treatment, they should seek immediate appropriate measures. Patients with weak renal function should have their potassium and creatinine levels regularly monitored while taking this medication. This medication may interact with other specific medications, so if any other medications are being taken, it is essential to inform healthcare professionals. Breastfeeding women should avoid taking this medication, and it is not recommended for children or adolescents under 18 years of age. Elderly patients may be more sensitive to this medication, so caution is needed when taking it, and dosage adjustments may be necessary. In case of overdose, symptoms such as hypotension, dizziness, and heart problems may occur, and immediate medical attention should be sought.

Side effects

  • Dizziness
  • peripheral edema
  • fainting
  • upper respiratory tract infection
  • pharyngitis
  • sinusitis
  • urinary tract infection
  • cystitis
  • sepsis
  • anemia
Show 100 more
  • thrombocytopenia
  • eosinophilia
  • leukopenia
  • hypersensitivity
  • anaphylactic reaction
  • hyperkalemia
  • hypoglycemia
  • hyponatremia
  • hyperglycemia
  • depression
  • insomnia
  • anxiety
  • confusion
  • drowsiness
  • headache
  • migraine
  • paresthesia
  • sensory impairment
  • dysgeusia
  • tremor
  • extrapyramidal disorder
  • muscle rigidity
  • visual impairment
  • diplopia
  • vertigo
  • tinnitus
  • palpitations
  • bradycardia
  • tachycardia
  • myocardial infarction
  • ventricular tachycardia
  • arrhythmia
  • atrial fibrillation
  • flushing
  • hypotension
  • orthostatic hypotension
  • vasculitis
  • cough
  • dyspnea
  • rhinitis
  • change in bowel habits
  • diarrhea
  • constipation
  • abdominal pain
  • dyspepsia
  • nausea
  • vomiting
  • dry mouth
  • gingival hyperplasia
  • abdominal discomfort
  • pancreatitis
  • gastritis
  • liver dysfunction
  • hepatic impairment
  • hepatitis
  • jaundice
  • increased liver enzymes
  • pruritus
  • hyperhidrosis
  • rash
  • hair loss
  • purpura
  • skin discoloration
  • eczema
  • erythema
  • angioedema
  • toxic skin rash
  • drug rash
  • urticaria
  • erythema multiforme
  • exfoliative dermatitis
  • Stevens-Johnson syndrome
  • photosensitivity reaction
  • joint swelling
  • muscle cramps
  • arthralgia
  • myalgia
  • lumbar pain
  • limb pain
  • tendon pain
  • renal impairment
  • urinary disorders
  • polyuria
  • nocturia
  • erectile dysfunction
  • gynecomastia
  • edema
  • asthenia
  • fatigue
  • chest pain
  • malaise
  • influenza-like illness
  • increased liver enzymes
  • increased blood creatinine
  • weight gain
  • weight loss
  • increased blood uric acid
  • increased blood creatine phosphokinase
  • decreased hemoglobin
  • intestinal vascular edema

Not everyone experiences these, and they can vary from person to person.

Storage

This medication may be sensitive to light, so it should be stored in a container that blocks light. Additionally, it is best to store the medication at room temperature between 1°C and 30°C. Proper storage helps maintain the efficacy and safety of the medication.

Appearance and packaging

Appearance

White or whitish rectangular tablet

Package unit

30 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.